{"slug":"leukaemia","tag":"leukaemia","variants":["leukaemia"],"description":"People whose work centres on leukaemia.","count":17,"kinds":{"person":17},"related":[{"slug":"clinician-scientist","tag":"clinician-scientist","shared":9},{"slug":"leadership","tag":"leadership","shared":8},{"slug":"trialist","tag":"trialist","shared":7},{"slug":"haematology","tag":"haematology","shared":6},{"slug":"paediatric","tag":"paediatric","shared":3},{"slug":"immunotherapy","tag":"immunotherapy","shared":2},{"slug":"clinical-trials","tag":"clinical trials","shared":1},{"slug":"guidelines","tag":"guidelines","shared":1},{"slug":"targeted-therapy","tag":"targeted-therapy","shared":1}],"records":[{"id":"adrian-ochsenbein","kind":"person","name":"Adrian Ochsenbein","route":"/people/adrian-ochsenbein/","tldr":"Bern medical oncology chief whose lab targets leukaemia stem cells and CD70 signalling."},{"id":"konstanze-doehner","kind":"person","name":"Konstanze Döhner","route":"/people/konstanze-doehner/","tldr":"Ulm haematologist and President of the European Hematology Association, a leading figure in the molecular genetics and risk classification of acute myeloid leukaemia."},{"id":"brian-huntly","kind":"person","name":"Brian Huntly","route":"/people/brian-huntly/","tldr":"Cambridge haematologist and EHA President Elect whose laboratory studies how epigenetic regulators drive leukaemia and how they can be targeted."},{"id":"tim-somervaille","kind":"person","name":"Tim Somervaille","route":"/people/tim-somervaille/","tldr":"Haematologist and Senior Group Leader at CRUK Manchester Institute studying the transcriptional drivers of acute myeloid leukaemia."},{"id":"marco-vignetti","kind":"person","name":"Marco Vignetti","route":"/people/marco-vignetti/","tldr":"Haematologist who presides over GIMEMA, Italy's adult haematological malignancies cooperative group, and co-authored its chemotherapy-free Ph+ ALL trial."},{"id":"antonio-cuneo","kind":"person","name":"Antonio Cuneo","route":"/people/antonio-cuneo/","tldr":"Ferrara haematologist and CLL expert who chairs GIMEMA's Scientific Committee."},{"id":"martin-bornhauser","kind":"person","name":"Martin Bornhäuser","route":"/people/martin-bornhauser/","tldr":"Dresden haematologist and transplant physician who co-directs the NCT/UCC Dresden cancer centre and leads AML transplant trials."},{"id":"thomas-kindler","kind":"person","name":"Thomas Kindler","route":"/people/thomas-kindler/","tldr":"Haematologist-oncologist who directs the University Cancer Center Mainz at Universitätsmedizin Mainz."},{"id":"hubert-serve","kind":"person","name":"Hubert Serve","route":"/people/hubert-serve/","tldr":"Leukaemia specialist heading haematology and oncology at University Hospital Frankfurt and co-author of the pivotal RATIFY midostaurin trial."},{"id":"herve-dombret","kind":"person","name":"Hervé Dombret","route":"/people/herve-dombret/","tldr":"Paris haematologist who led AZA-AML-001, the trial that showed azacitidine can extend survival for older people with acute myeloid leukaemia who cannot have intensive chemotherapy."},{"id":"francesco-lo-coco","kind":"person","name":"Francesco Lo-Coco","route":"/people/francesco-lo-coco/","tldr":"Italian haematologist who led APL0406, the trial that showed acute promyelocytic leukaemia can be cured with all-trans retinoic acid and arsenic trioxide alone, without chemotherapy."},{"id":"miguel-sanz","kind":"person","name":"Miguel A. Sanz","route":"/people/miguel-sanz/","tldr":"Spanish haematologist who led the PETHEMA trials that tailored acute promyelocytic leukaemia treatment to relapse risk, and who chaired the European LeukemiaNet recommendations for the disease."},{"id":"jeffrey-lancet","kind":"person","name":"Jeffrey E. Lancet","route":"/people/jeffrey-lancet/","tldr":"Florida leukaemia doctor who led the phase 3 trial of CPX-351, the liposomal form of daunorubicin and cytarabine that lengthened survival for older people with secondary acute myeloid leukaemia."},{"id":"jan-burger","kind":"person","name":"Jan A. Burger","route":"/people/jan-burger/","tldr":"Leukaemia specialist who was lead author of RESONATE-2, the trial that made ibrutinib a first-line treatment for chronic lymphocytic leukaemia in older patients."},{"id":"kimberly-dunsmore","kind":"person","name":"Kimberly P. Dunsmore","route":"/people/kimberly-dunsmore/","tldr":"Paediatric oncologist who chaired COG AALL0434, the largest trial ever run in childhood T-cell leukaemia, which showed that adding nelarabine improves disease-free survival."},{"id":"rob-pieters","kind":"person","name":"Rob Pieters","route":"/people/rob-pieters/","tldr":"Dutch paediatric oncologist who led the international Interfant trials for babies with leukaemia and helped create the Princess Máxima Center, which brought all Dutch childhood cancer care into one hospital."},{"id":"inge-van-der-sluis","kind":"person","name":"Inge M. van der Sluis","route":"/people/inge-van-der-sluis/","tldr":"Dutch paediatric oncologist who led the study showing that adding one course of blinatumomab to chemotherapy sharply improves survival for babies with KMT2A-rearranged leukaemia."}]}